Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigating Hypercapnia to Treat Neurogenic Orthostatic Hypotension
NCT05295810Recruiting
- Sponsor
- University of Calgary
- Start
- Mar 2022
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Open-label trial (5 arms), sponsored by University of Calgary. Primary endpoint: Change in Blood Pressure. Started Mar 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05295810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05295810.